Ram R. Miller

机构：Novartis (Switzerland), Novartis Institutes for BioMedical Research · ORCID：0000-0002-2481-2834

发表论文 85 篇 · 总被引 5089 次 · h-index 34

代表论文

• Effect of Bimagrumab vs Placebo on Body Fat Mass Among Adults With Type 2 Diabetes and Obesity (2021 · JAMA Network Open · 被引 328)
• Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project) (2022 · BMJ · 被引 317)
• Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults (2020 · JAMA Network Open · 被引 172)
• A Roadmap to Inform Development, Validation and Approval of Digital Mobility Outcomes: The Mobilise-D Approach (2020 · Digital Biomarkers · 被引 150)
• Connecting real-world digital mobility assessment to clinical outcomes for regulatory and clinical endorsement–the Mobilise-D study protocol (2022 · PLoS ONE · 被引 84)
• Effect of a Multicomponent Home-Based Physical Therapy Intervention on Ambulation After Hip Fracture in Older Adults (2019 · JAMA · 被引 80)